Publications
Apr 3, 2025
- Biophys J.
Glycolysis model shows that allostery maintains high ATP and limits accumulation of intermediates
Choe M, Einav T, Phillips R, Titov DV
Mar 28, 2025
- EBioMedicine
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials.
Cooper CL, Morrow G, Yuan M, Postler TS, Neal ML, Cross RW, Woolsey C, Agans KN, Borisevich V, McNamara RP, Atyeo C, Roy V, Germosen D, Hou F, Li SL, Reiserova L, Choi Y, Wilson A, Wagner D, Wallace-Selman O, Carpov A, Geng F, Frederick DJ, DeStefano J, Ercolini AM, Enriquez AS, Hastie KM, Ramos da Silva S, Sayeed E, Coleman JW, Kilianski A, Alter G, Saphire EO, Aitchison JD, Geisbert TW, Gupta SB, Feinberg MB, Parks CL.
Jan 9, 2025
- bioRxiv [Preprint]
Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters.
da Silva Antunes R, Fajardo-Rosas V, Yu ED, Gálvez RI, Abawi A, Alexandar Escarrega E, Martínez-Pérez A, Johansson E, Goodwin B, Frazier A, Dan JM, Crotty S, Seumois G, Weiskopf D, Vijayanand P, Sette A
Mar 31, 2025
- EBioMedicine
Mapping the antibody response to Lassa virus vaccination of non-human primates
Enriquez AS, Avalos RD, Parekh D, Cooper CL, Morrow G, Geisbert TW, Parks CL, Hastie KM, Saphire EO.
Jan 13, 2025
- Front Immunol
Specific immune response to M. tuberculosis and ability to in vitro control mycobacterial replication are not impaired in subjects with immune-mediated inflammatory disease and tuberculosis infection
Farroni C, Altera AMG, Salmi A, Vanini V, Cuzzi G, Lindestam Arlehamn CS, Sette A, Delogu G, Palucci I, Sbarra S, Aiello A, Picchianti-Diamanti A, Gualano G, Palmieri F, Goletti D, Petruccioli E
Jan 22, 2025
- The Journal of experimental medicine
The XCL1-XCR1 axis supports intestinal tissue residency and antitumor immunity
Ferry A, Mempel KM, Monell A, Reina-Campos M, Scharping NE, Heeg M, Takehara KK, Schokrpur S, Kuo N, Saddawi-Konefka R, Gutkind JS, Goldrath AW.
Feb 24, 2025
- JCI Insight
Frequency of dengue virus-specific T cells is related to infection outcome in endemic settings
Gálvez RI, Martínez-Pérez A, Escarrega EA, Singh T, Zambrana JV, Balmaseda Á, Harris E, Weiskopf D
Jan 16, 2025
- Curr Pharm Biotechnol
A Roadmap Towards the Identification and Validation of Conserved T Cell Epitope Regions in Viral Pathogen Families with Pandemic Potential
Grifoni A, Sidney J, Weiskopf D, Scheuermann RH, Sette A
Mar 29, 2025
- bioRxiv
The spontaneous neoantigen-specific CD4 + T cell response to a growing tumor is functionally and phenotypically diverse
Griswold, R. Q., Brightman, S. E., Zavala, K. S., Ordaz-Arias, M. A., Djassemi, N., Thota, R. R., Naradikian, M. S., Dose, H., Alarcon, S., Pandurangan, V., Peters, B., Miller, A. M., Cohen, E. E. W., & Schoenberger, S. P.
Feb 1, 2025
- Allergy
Comparison of cd30l and ox40l reveals cd30l as a promising therapeutic target in atopic dermatitis
Gupta RK, Figueroa DS, Ay F, Causton B, Abdollahi S, Croft M
Feb 3, 2025
- Nature Communications
Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane.
Hastie KM, Salie ZL, Ke Z, Halfmann PJ, DeWald LE, McArdle S, Grinyó A, Davidson E, Schendel SL, Hariharan C, Norris MJ, Yu X, Chennareddy C, Xiong X, Heinrich M, Holbrook MR, Doranz B, Crozier I, Kawaoka Y, Branco LM, Kuhn JH, Briggs JAG, Worwa G, Davis CW, Ahmed R, Saphire EO.
Apr 1, 2025
- Cell Rep Med
Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipients
Hu M, Oliveira APBN, Fang Z, Feng Y, Miranda M, Kowli S, Arunachalam PS, Vasudevan G, Hui HS, Grifoni A, Sette A, Litvack M, Rouphael N, Suthar MS, Ji X, Maecker HT, Hagan T, Dhillon G, Nicolls MR, Pulendran B
